A 9-Year Follow-Up Study of the Immunogenicity and Long-Term Efficacy of Plasma-Derived Hepatitis B Vaccine in High-Risk Chinese Neonates

Clinical Infectious Diseases

Volumn 17, Issue 3, 1993, Pages 475-479

  Lieming, Ding ^a,b   Mintai, Zhang ^a,b   Yinfu, Wang ^a,b   Shaochon, Zhou ^a,b   Weiqin, Kong ^a,b   Smego, Raymond A ^a,b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS E ANTIGEN; IMMUNOGLOBULIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHINESE; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFECTION CONTROL; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; SEROLOGY;

CHILD; CHILD, PRESCHOOL; CHINA; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMAN; IMMUNIZATION, PASSIVE; INFANT; INFANT, NEWBORN; RISK; TIME FACTORS;

EID: 0027257901     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/17.3.475     Document Type: Article

References (29)

1. Smego RA Jr, Halsey NA. The case for routine hepatitis B immunization in infancy for populations at increased risk. Ped Infect Dis J 1987;6:11-9.
2. West DJ, Calandra GB, Ellis RW. Vaccination of infants and children against hepatitis B. Pediatr Clin N Am 1990;37:585-601.
3. Francis DP. Selective primary health care: strategies for control of disease in the developing world. III. Hepatitis B virus and its related diseases. Rev Infect Dis 1983;5:322-30.
4. Maupas P, Chiron JP, Goudeau A. Active immunization against hepatitis B in an area of high endemicity: part II: prevention of early infection of the child. Prog Med Virol 1981;27:185-201.
5. Wong VCW, Ip HMH, Reesink HW, et al. Prevention of HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet 1984;1:921-6.
6. Beasley RP, Hwang L-Y. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983;147:185-90.
7. Piazza M, Piciotto L, Villari R, et al. Hepatitis B immunization with a reduced number of doses in newborn babies and children. Lancet 1985;1:949-51.
8. Goudeau A, Lo KJ, Coursaget P, et al. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers: preliminary results of active and passive-active immunization. Dev Biol Stand 1983;54:399-404.
9. Lo KJ, Tsai YT, Lee SD, et al. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Hepatogastroenterology 1985;32:65-8.
10. Lo K-J, Tsai Y-T, Lee S-C, et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 1985;152:817-22.
11. Maupas P, Chiron P, Barin F, et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children: controlled trial in an endemic area (Senegal). Lancet 1981;1:289-92.
12. Barin F, Goudeau A, Denis F, et al. Immune response in neonates to hepatitis B vaccine. Lancet 1982;1:251-3.
13. Prozesky OW, Stevens CK, Szmuness W, et al. Immune response to hepatitis B vaccine in newborns. J Infect 1983;7(suppl):53-5.
14. McLean AA, Hilleman MR, McAleer WJ, et al. Summary of worldwide experience with H-B Vax (B, MSD). J Infect 1983;7(suppl):95-104.
15. Coursaget P, Chiron JP, Bazin F, et al. Hepatitis B vaccine immunization of children and newborns in an endemic area (Senegal). Dev Biol Stand 1983;54:245-57.
16. Lee GC-Y, Hwang L-Y, Beasley RP, et al. Immunogenicity of hepatitis B vaccine in healthy Chinese neonates. J Infect Dis 1983;148:526-9.
17. Medical news: HBV vaccine immunogenic in neonates. JAMA 1983;250:19.
18. Scaravelli C, Calligari G, Mariani G, et al. RIA evaluation of antibody levels in neonates from HBsAg-positive mothers after active, passive, and combined immunoprophylaxis. Gynecol Obstet Invest 1984;17:208-12.
19. Yong-Ji W, Yong K, Zhi-Li G, et al. Hepatitis B vaccine in neonates: induction of anti-HBs immune response and interruption of maternal HBsAg transmission. Chin Med J 1985;93:265-70.
20. Xu ZY, Lin CB, Francis DP, et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind, placebo-controlled and comparative trial. Pediatrics 1985;76:713-8.
21. Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.
22. Taylor PE, Stevens CE. Persistence of antibodies to hepatitis B surface antigen after vaccination with hepatitis B vaccine. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R Liss, 1988:995-7.
23. Gibas A, Watkins E, Hinkle C, Dienstag JL. Long-term persistence of protective antibody after vaccination of healthy adults. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R Liss, 1988:998-1001.
24. Wainwright RB, McMahon BJ, Bulkow LR, et al. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yuplik Eskimo population. JAMA 1989;261:2362-6.
25. Wainwright RB, McMahon BJ, Bulkow LR, Parkinson AJ, Garoster AP. Protection provided by hepatitis B vaccine in a Yuplik Eskimo population: seven-year results. Arch Intern Med 1991;151:1634-7.
26. Jilg W, Schmidt M, Edinhardt ZR. Hepatitis vaccination: how long does protection last? Lancet 1984;2:458.
27. Centers for Disease Control. Update on hepatitis B prevention: recommendations of the immunization practices advisory committee. MMWR 1987;36:353-60.
28. Hadler SC. Are booster doses of hepatitis B vaccine necessary? [editorial]. Ann Intern Med 1988;108:458-9.
29. Guan R, Tay HH, Yap I, Smith R, Tan LH. The immune responses of low-dose recombinant DNA hepatitis B vaccine in teenagers in Singapore. Trans R Soc Trop Med Hyg 1990;84:731-2.